Our Gene Therapy Pipeline is revolutionizing hearing care by targeting the root causes of hearing loss. Through cutting-edge gene-editing technologies, we are developing precise and effective treatments to restore hearing function. By bridging scientific innovation with real-world solutions, we are shaping a future where hearing loss is no longer a lifelong challenge.
Human gene therapy seeks to modify or manipulate the expression of a gene or to alter the biological properties of living cells for therapeutic use. Gene therapy is a technique that modifies a person’s genes to treat or cure disease. Gene therapies can work by several mechanisms: Replacing a disease-causing gene with a healthy copy of the gene, inactivating a disease-causing gene that is not functioning properly, and introducing a new or modified gene into the body to help treat disease. Gene therapy products are being studied to treat diseases including cancer, genetic diseases (like hearing loss and deafness), and infectious diseases.
Gene therapy is rapidly emerging as a groundbreaking solution for hearing loss, becoming both medically and commercially viable. With advancements in gene-editing tools like CRISPR/Cas9, developing gene therapy products is now more realistic, efficient, and affordable than ever before.
With cutting-edge innovations and growing global support, gene therapy is shaping the future of hearing restoration and personalized medicine.
Rescue Hearing Inc. is advancing a cutting-edge pipeline of gene therapy solutions targeting various forms of hearing loss. From progressive hearing impairment to balance disorders and neurodegenerative conditions, each product is designed to revolutionize hearing care through innovation and scientific breakthroughs.
At Rescue Hearing Inc. (RHI), we are pioneering the development of gene therapy solutions to address the root causes of progressive hearing loss. Our innovative pipeline includes two groundbreaking products—RHI100 and RHI200—designed to restore hearing and transform lives.
